Access to syringes in three Russian cities: Implications for syringe distribution and coverage

International Journal of Drug Policy

Volumn 19, Issue SUPPL. 1, 2008, Pages 25-36

  Sarang, Anya ^a   Rhodes, Tim ^b   Platt, Lucy ^b  

^a Russian Harm Reduction Network   (Russian Federation)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Coverage; Injection drug use; Pharmacies; Qualitative; Russia; Syringe exchange

Indexed keywords

ARTICLE; HEALTH CARE POLICY; HEALTH SERVICE; HEALTH SURVEY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INTERVIEW; NEEDLE; PHARMACY; PRIORITY JOURNAL; SOCIAL SUPPORT; SYRINGE;

ADOLESCENT; ADULT; COST-BENEFIT ANALYSIS; DATA COLLECTION; FEMALE; HEALTH SERVICES ACCESSIBILITY; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEEDLE-EXCHANGE PROGRAMS; PHARMACIES; PREVENTIVE HEALTH SERVICES; RISK-TAKING; RUSSIA; SUBSTANCE ABUSE, INTRAVENOUS; SYRINGES; URBAN HEALTH SERVICES;

EID: 41149125851     PISSN: 09553959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugpo.2007.11.008     Document Type: Article

References (59)

1. Aceiajs C., Hickman M., Donoghoe M.C., Burrows D., and Stuikyte R. Access and coverage of needle and syringe programmes in Central and Eastern Europe and Central Asia. Addiction 102 (2007) 1244-1250
2. Archibald C., Ofner M., Strathdee S., Patrick D., Sutherland D., Rekart M., et al. Factors associated with frequent needle exchange program attendance in injection drug users in Vancouver, Canada. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 17 (1998) 160-166
3. Badrieva, L., & Karchevsky, E. (2006). Situation Analysis on HIV-infection and Injecting Drug Use in Kazan. A report for the Intersectoral Commission on fight with AIDS at the Cabinet of Ministers of Republic of Tatarstan, Kazan (Russian language).
4. Bastos F.I., and Strathdee S. Evaluating effectiveness of syringe exchange programmes. Social Science and Medicine 51 (2000) 1771-1782
5. Bastos F., Malta M., Hacker M., Petersen M., Sudbrack M., Colombo M., et al. Assessing needle exchange operations in a poor Brazilian community. Substance Use and Misuse 41 (2006) 937-951
6. Bourgois P., and Bruneau J. Needle exchange, HIV Infection and the politics of science: Confronting Canada's cocaine injection epidemic with participant observation. Medical Anthropology 18 (2000) 325-350
7. Bluthenthal R.N., Kral A., Lorvick J., and Watters J.K. Impact of law enforcement on syringe exchange programs. Medical Anthrpology 18 (1997) 61-83
8. Bluthenthal R.N., Kral A.H., Gee L., Erringer E.A., and Edlin B.R. The effect of syringe exchange use on high-risk injection drug users: A cohort study. AIDS 14 (2000) 605-611
9. Bluthenthal R.N., Ridgeway G., Schell T., Anderson R., Flynn N.M., and Kral A.H. Examination of the association between syringe exchange program (SEP) dispensation policy and SEP client-level syringe coverage among injection drug users. Addiction 102 (2007) 638-646
10. Bruneau J., Brogly S.B., Tyndall M.W., Lamonthe F., and Franco E.L. Intensity of drug injection as a determinant of sustained injection cessation among chronic drug users. Addiction 99 (2004) 727-737
11. Burris S., Lurie P., Abrahamson D., and Rich J.D. Physician prescribing of sterile injection equipment to prevent HIV infection: Time for action. Annals of Internal Medicine 133 (2000) 218-226
12. Burrows D. A best practice model for harm reduction in the community and prisons in Russian federation (2001), The World Bank, Washington, DC
13. Burrows D. Rethinking coverage of needle exchange programs. Substance Use and Misuse 41 (2006) 1045-1048
14. Des Jarlais D.C., Grund J.-P., Milliken J., Paone D., Zadoretzky C., Perlis T., et al. HIV risk behaviour among participants of syringe exchange programs in Central/Eastern Europe and Russia. International Journal of Drug Policy 13 (2002) 165-170
15. Drucker E., Lurie P., Wodak A., and Alcabes P. Measuring harm reduction: The effects of needle and syringe exchange programs and methadone maintenance on the ecology of HIV. AIDS 12 Suppl. A (1998) S217-S230
16. Gibson D.R., Flynn N.M., and Perales D. Effectiveness of syringe exchange programs in reducing HIV risk behavior and HIV seroconversion among injecting drug users. AIDS 15 (2001) 1329-1341
17. Groseclose S.L., Weinstein B., Jones T.S., Valleroy L.A., Fehrs L.J., and Kassler W.J. Impact of increased legal access to needles and syringes on practices of injecting-drug users and police officers-Connecticut, 1992-1993. Journal of Acquired Immune Deficiency Syndromes 10 (1995) 82-89
18. Hammett T.M., Bartlett N.A., Chen Y., Ngu D., Cuong D.D., Phoung N.M., et al. Law enforcement influences on HIV prevention for injection drug users: Observations from a cross-border project in China and Vietnam. International Journal of Drug Policy 16 (2005) 235-245
19. Heimer R., Clair S., Teng W., Grau L.E., Khoshnood K., and Singer M. Effects of increasing syringe availability on syringe exchange use and HIV risk: Connecticut 1990-2001. Journal of Urban Health 79 (2002) 556-569
20. Heimer R. Community coverage and HIV prevention: Metrics for assessing HIV incidence through syringe exchange. International Journal of Drug Policy 19S (2008) S65-S73
21. Huo D., Bailey S.L., Garfein R.S., and Ouellet L.J. Changes in the sharing of drug injection equipment among street-recruited injection drug users in Chicago, Illlinois, 1994-1996. Substance Use and Misuse 40 (2005) 63-76
22. Hunt N. Public health or human rights: What comes first?. International Journal of Drug Policy 15 (2004) 231-237
23. Institute of Medicine of National Academies. Preventing HIV infection among injecting drug users in high-risk countries: An assessment of the evidence (2007), National Academies Press, Washington, DC
24. International Narcotics Control Board (INCB). (2006). Report of the International Narcotics Control for 2005. (E/INCB/2005/1). United Nations, New York. Available at: http://www.incb.org/incb/en/annual_report_2005.html (last accessed August 13, 2007).
25. Irwin K., Karchevsky E., Heimer R., and Badrieva L. Secondary syringe exchange as a model for HIV prevention programs in the Russian federation. Substance Use & Misuse 41 (2006) 979-999
26. MacDonald M., law M., Kaldor J., Hales J., and Dore G.J. Effectiveness of needle and syringe programmes for preventing HIV transmission. International Journal of Drug Policy 14 (2003) 353-357
27. Miller C.L., Tyndall M., Spittal P., Li K., Palepu A., and Schechter M.T. Risk-taking behaviours among injecting drug users who obtain syringes from pharmacies, fixed sites, and mobile van needle exchanges. Journal of Urban Health 79 (2002) 257-265
28. Moshkovich G.F., Pikovskaya E.D., Fedotova N.V., Shilov D.V., Kuznetsov A.V., and Moiseev A.P. Prevention of HIV infection and other blood borne infections amongst injecting drug users in Nizhny Novgorod associated with harm reduction. Journal of Microbiology, Epidemiology and Immunobiology 4 (2000) 78-82 (Russian language)
29. Open Health Institute. (2006). Harm Reduction Programs in the Civilian and Prison Sectors of the Russian Federation: Assessment of Best Practices. Moscow.
30. Ouellet L., Huo D., and Bailey S.L. HIV risk practices among needle exchange users and nonusers in Chicago. Journal of Acquired Immune Deficiency Syndromes 37 (2004) 1187-1196
31. Parsons J., Hickman M., Turnbull P.J., Stimson G.V., Judd A., and Roberts I. Over a decade of syringe exchange: Results from 1997 UK survey. Addiction 97 (2002) 845-850
32. Platt L., Hickman M., Rhodes T., Mikhailova L., Karavashkin V., Vlasov A., et al. The prevalence of injecting drug use in a Russian city: Implications for harm reduction and coverage. Addiction 99 (2004) 1430-1438
33. Pouget E.R., Deren S., Fuller C., Blaney S., McMahon J., Kang S.Y., et al. Receptive syringe sharing among injection drug users in Harlem and the Bronx during the New York State Expanded Syringe Access Demonstration Program. Journal of Acquired Immune Deficiency Syndromes 39 (2005) 471-477
34. Power R., and Nozhkina N. Correspondence: The value of process evaluation in sustaining HIV harm reduction in the Russian Federation. AIDS 16 (2002) 303-304
35. Remis R.S., Bruneau J., and Hankins C.A. Enough sterile syringes to prevent HIV transmission among injection drug users in Montreal?. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 18 Suppl. 1 (1998) S57-S59
36. Rhodes T., Sarang A., Bobrik A., Bobkov E., and Platt L. HIV Transmission and HIV prevention associated with injecting drug use in the Russian Federation. International Journal of Drug Policy 15 (2004) 1-16
37. Rhodes T., Judd A., Mihailova L.A., Sarang A., Khutorskoy M., Platt L., et al. Injecting equipment sharing among injecting drug users in Togliatti City, Russia: Maximising the protective effects of syringe distribution. Journal of Acquired Immune Deficiency Syndromes 35 (2004) 293-300
38. Rhodes T., Mikhailova L., Sarang A., Lowndes C.L., Rylkov A., Khutorskoy M., et al. Situational factors influencing drug injecting, risk reduction and syringe exchange in Togliatti City, Russian Federation: A qualitative study of micro risk environment. Social Science and Medicine 57 (2003) 39-54
39. Rhodes T., Platt L., Maximova S., Koshkina E., Latshevskaya N., Hickman M., et al. Prevalence of HIV, hepatitis C and syphilis among injecting drug users in Russia: A multi-city study. Addiction 101 (2006) 252-266
40. Rhodes T., Platt L., Sarang A., Vlasov A., Mikhailova L., and Monaghan G. Street policing, injecting drug use and harm reduction in a Russian city: A qualitative study of police perspectives. Journal of Urban Health 83 (2006) 911-925
41. Riley D., Beilenson P., Vlahov D., Smith L., Koenig M., Jones T.S., et al. Operation red box: A pilot project of needle and syringe drop boxes for injection drug users in East Baltimore. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 18 Suppl. 1 (1998) S120-S125
42. Ritchie J., and Spencer L. Qualitative data analysis for applied policy research. In: Bryman A., and Burgess R.G. (Eds). Analysing qualitative data (1994), Routledge, London 173-194
43. Russian Harm Reduction Network (RHRN). (2005). Results of the Survey of Harm Reduction Projects. Unpublished document available by request from the RHRN info@harmreduction.ru.
44. Sarang A., Stuikyte R., and Bykov R. Implementation of harm reduction in Central and Eastern Europe and Central Asia. International Journal of Drug Policy 18 (2007) 129-135
45. Sarang, A., Rhodes, T., & Platt, L. (2007b) Ways to Improve Access to Sterile Syringes for Injecting Drug Users in Russian Cities, Moscow: Russian Harm Reduction Network. Available at http://www.harmreduction.ru/files/vssv_a_report_final_bw.zip (last accessed August 13, 2007) (Russian language).
46. Sarang A., Rhodes T., Platt L., Kirzhanova V., Shelkovnikova O., Volnov V., et al. Drug injecting and syringe use in the HIV risk environment of Russian penitentiary institutions: Qualitative study. Addiction 101 (2006) 1787-1796
47. Schechter M., Strathdee S., and Cornalisse P. Do needle exchange programs increase the spread of HIV among injection drug users?: An investigation of the Vancouver outbreak. AIDS 13 6 (1999) F45-F51
48. Sharma M., Burrows D., and Bluthenthal R. Coverage of HIV prevention programmes for injection drug users: Confusions, aspirations, definitions and ways forward. International Journal of Drug Policy 18 (2007) 92-98
49. Sivatcheva I., Trofimov V., Gonchar E., Gorodetskaya I., and Lukicheva T. Some results of work of Pskov prevention program among intravenous drug users on limiting the spread of HIV prevention. Proceedings of Russian Scientific-Practice Conference on HIV and Blood Borne Viral Hepatitis. Suzdal (Russian language) (2002) 68-70
50. Strathdee S.A., Patrick D.M., Currie S.L., Cornelisse P.G., Rekart M.L., Montaner J.S., et al. Needle exchange is not enough: Lessons from the Vancouver injecting drug use study. AIDS 11 (1997) F59-F65
51. Strathdee S., and Vlahov D. The effectiveness of needle exchange programs: A review of the science and Policy. AIDS Science 1 (2001) 1-33
52. United Nations Joint Programme on HIV/AIDS (UNAIDS). (2006) High Coverage Sites: HIV Prevention among Injecting Drug Users in Transitional and Developing Countries, Geneva: UNAIDS. Available at: http://data.unaids.org/Publications/IRC-pub07/JC1254-HighCoverageIDU_en.pdf (last accessed 13 August, 2007).
53. Vickerman P., Hickman M., Rhodes T., and Watts C. Model projections on the required coverage of syringe distribution to prevent HIV epidemics among injecting drug users. Journal of Acquired Immune Deficiency Syndromes 42 (2006) 355-361
54. Victoria C.S., Huttly S.R., Fuchs S.C., and Olinto M.T.A. The role of conceptual frameworks in epidemiological analysis: A hierarchical approach. International Journal of Epidemiology 26 (1997) 224-227
55. Vlahov D. The role of epidemiology in needle exchange programs. American Journal of Public Health 90 (2000) 1390-1392
56. Wodak A., and Cooney A. Effectiveness of sterile needle and syringe programmes. International Journal of Drug Policy 16 (2006) 31-44
57. Wood E., Tyndall M., Spittal P.M., Li K., Hogg R.S., Monanter J.S., et al. Factors associated with persistent high-risk syringe sharing in the presence of an established needle exchange programme. AIDS 16 (2002) 941-943
58. Wood E., Tyndall M.W., Spittal P.M., Li K., Hogg R.S., O'Shaughnessy M.V., et al. Needle exchange and difficulty with needle access during an ongoing HIV epidemic. International Journal of Drug Policy 13 (2002) 95-102
59. World Health Organization, United Nations Office of Drug Control and United Nations Joint Programme on HIV/AIDS. (2007). Technical Guide for Countries to set Targets for Universal Access to HIV Prevention and Care for Injecting Drug Users, Copenhagen: WHO Regional Office for Europe.